| Size | Price | |
|---|---|---|
| Other Sizes |
| ln Vitro |
Chlorfenuron is a commonly used plant growth regulator that makes kiwi fruits bigger and heavier. The Sulforhodamine B assay was used to investigate the cytotoxicity of clofenuron and its metabolites against CHO cells. An IC50 of 12.12±2.14 μM for chlorfenuron indicates considerable cytotoxicity to CHO cells[1]. Chlorfenuron has a half-life of 15.8–23.0 days. The pulp has a final residual chlorfenuron content of ≤0.002 mg/kg, with the peel containing the majority of the residue. According to the risk assessment, there is not a substantial risk to health associated with clofenuron found in citrus fruits. Consequently, it is safe to apply chlorfenuron on citrus fruits [2].
|
|---|---|
| ADME/Pharmacokinetics |
Absorption, Distribution and Excretion
In the primary and bile excretion studies, at least four Sprague-Dawley rats per pair of males and females were administered 100 mg/kg of CPPU-UL-phenyl-(14)C (radiochemical purity: 99.16%; specific activity: 28.04 mCi/mmol) by gavage, mixed with unlabeled chlorpyrifos technical (purity: 98.2%). In the primary study, urine, feces, and air samples were collected periodically over 7 days post-administration. In the bile excretion study, bile samples were collected periodically via bile duct cannulation over 72 hours post-administration. The primary route of excretion was urine (male rats: urine: 79%, feces: 16%; female rats: urine: 68%, feces: 28%). Within 24 hours post-administration, 82% of the radiolabeled material was recovered in males and 66% in females. Less than 0.1% of the administered dose of radiolabeled material was recovered from the air. The excretion half-life of the radiolabeled material in urine and feces was 13 to 16 hours in both sexes. Less than 1% of the administered dose of radiolabeled material was recovered from tissues 7 days after administration. In the bile excretion study, 23% and 20% of the administered radiolabeled material were recovered from bile in males and females, respectively. However, its absorption kinetics could not be directly assessed because urine or fecal samples were not collected simultaneously from these study animals. Absorption can be achieved through leaves, stems, cotyledons, and germinating seeds. Metabolites/Metabolites At least four Sprague-Dawley rats (half male and half female) were administered 100 mg/kg of CPPU-UL-phenyl-(14)C (radiochemical purity: 99.16%; specific activity: 28.04 mCi/mmol) by gavage, supplemented with unlabeled chlorpyrifos technical (purity: 98.2%). The main metabolite recovered in urine was CPPU sulfate with a substituted benzene ring. This metabolite accounted for 84% and 57% of the administered dose in male and female rat urine, respectively. Other metabolites were also products of benzene ring hydroxylation. Hydroxyl-CPPU was the main metabolite recovered in feces, with males and females recovering 11% and 18% of the administered dose, respectively. Biological Half-Life At least four Sprague-Dawley rats (half male and half female) were administered 100 mg/kg of CPPU-UL-phenyl-(14)C (radiochemical purity: 99.16%; specific activity: 28.04 mCi/mmol) by gavage, supplemented with unlabeled chlorpyrifos technical (purity: 98.2%). The excretory half-life in urine and feces was 13 to 16 hours in both male and female rats. |
| References |
|
| Additional Infomation |
Chlorpyrifos belongs to the phenylurea class of compounds. Its structure is a urea group, with phenyl and 2-chloropyridin-4-yl groups substituted at positions 1 and 3, respectively. It is a widely used plant growth regulator in agriculture to improve fruit quality and increase fruit size. It is a diphenylurea derivative, belonging to the cytokinin class of growth stimulants, used as a plant growth regulator (PGR) to promote fruit set, increase fruit size, and improve yield. It can be absorbed by most plant tissues and works synergistically with natural auxins to promote cell division and growth. In the United States, it has been approved for use in kiwifruit and grapes, but in China, it has been linked to watermelon bursting incidents. Chlorpyrifos is commonly used in horticulture to promote the growth of kiwifruit and grapes.
Mechanism of Action Septin is a filamentous GTPase associated with the cell membrane and cytoskeleton, playing a crucial role in cell division and cell morphogenesis. Septin is associated with various human diseases, including cancer and neuropathy. Small molecules capable of reversibly disrupting septin organization and function will be valuable tools for elucidating septin function and could be used to treat septin-related diseases. Chlorpyrifos is a plant cytokinin that has previously been shown to disrupt the localization of septa proteins in budding yeast. However, it remains unclear whether chlorpyrifos directly targets septa proteins and whether it affects the organization and function of septa proteins in mammalian cells. In this study, we found that chlorpyrifos altered septa protein assembly in vitro without affecting actin or tubulin polymerization. In living mammalian cells, chlorpyrifos inhibited dynamic changes in septa proteins and induced the assembly of abnormally large septa protein structures. Chlorpyrifos exhibited low cytotoxicity, and these effects were reversible upon chlorpyrifos elution. Notably, chlorpyrifos treatment induced defects in mitosis and cell migration, with a phenotype similar to that induced by small interfering RNA (siRNA)-mediated septa protein depletion. It can promote cell division, differentiation, and development; induce callus budding and control apical dominance; break lateral bud dormancy and promote germination; delay senescence and maintain chlorophyll content in detached leaves; regulate nutrient transport; and promote fruit formation, among other benefits. |
| Molecular Formula |
C12H10CLN3O
|
|---|---|
| Molecular Weight |
247.68
|
| Exact Mass |
247.051
|
| CAS # |
68157-60-8
|
| Related CAS # |
Forchlorfenuron-d5;1398065-87-6
|
| PubChem CID |
93379
|
| Appearance |
White to off-white solid powder
|
| Density |
1.3±0.1 g/cm3
|
| Boiling Point |
426.5±55.0 °C at 760 mmHg
|
| Melting Point |
170-172°C
|
| Flash Point |
211.7±31.5 °C
|
| Vapour Pressure |
0.0±1.1 mmHg at 25°C
|
| Index of Refraction |
1.629
|
| LogP |
3.83
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
17
|
| Complexity |
256
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
GPXLRLUVLMHHIK-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C12H10ClN3O/c13-11-8-10(6-7-14-11)16-12(17)15-9-4-2-1-3-5-9/h1-8H,(H2,14,15,16,17)
|
| Chemical Name |
1-(2-chloropyridin-4-yl)-3-phenylurea
|
| Synonyms |
CPPU; 4PU30 cpd; Forchlorfenuron
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ≥ 100 mg/mL (~403.75 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (10.09 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (10.09 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (10.09 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.0375 mL | 20.1873 mL | 40.3747 mL | |
| 5 mM | 0.8075 mL | 4.0375 mL | 8.0749 mL | |
| 10 mM | 0.4037 mL | 2.0187 mL | 4.0375 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.